Gemma Published scientific articles
Table of Contents
Autism research
Troisi et al., 2020. Genome, Environment, Microbiome and Metabolome in Autism (GEMMA) Study Design: Biomarkers Identification for Precision Treatment and Primary Prevention of Autism Spectrum Disorders by an Integrated Multi-Omics Systems Biology Approach. Brain Sci. 2020 Oct 16;10(10):743. DOI: 10.3390/brainsci10100743
Autism Spectrum Disorder (ASD) affects about 1 in 54 children in the U.S.A., with a significant increase since 1960. While improved awareness and clinical practices may explain some of this rise, they do not fully account for it. Research suggests a link between ASD and gut microbiota due to gastrointestinal issues in many affected children. Current studies are limited in understanding the mechanisms of ASD. The GEMMA study, supported by the European Commission, aims to follow at-risk infants (because they are siblings of autistic children) from birth to identify biomarkers for ASD development, involving both clinical trials and pre-clinical studies to explore microbiome associations and potential treatment responses.
Needham et al., 2021. Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry. 2021 Mar 1;89(5):451-462. doi: 10.1016/j.biopsych.2020.09.025
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by impaired social communication and repetitive behaviors, along with metabolic imbalances and gastrointestinal dysfunction. This study aimed to explore non-behavioral features of ASD by analyzing molecular signatures in plasma and fecal samples from children with ASD and typically developing controls using mass spectrometry. Key differences in amino acid, lipid, and xenobiotic metabolism were identified, indicating oxidative stress and mitochondrial dysfunction. The study also found correlations between metabolite profiles and clinical behavior scores, suggesting a link between metabolism, gut physiology, and behavioral traits, which may help in developing molecular biomarkers for ASD.
Beopoulos A. et al. Autonomic Nervous System Neuroanatomical Alterations Could Provoke and Maintain Gastrointestinal Dysbiosis in Autism Spectrum Disorder (ASD): A Novel Microbiome-Host Interaction Mechanistic Hypothesis. Nutrients. 2021 Dec 24;14(1):65. doi: 10.3390/nu14010065
The article discusses how dysbiosis, often caused by environmental and lifestyle factors, may play a role in autism spectrum disorder (ASD). It suggests that gut microbiota imbalance in ASD might be linked to dysfunction in the autonomic nervous system, leading to a vicious cycle of gut-brain axis disruption and persistent dysbiosis.
Lombardi and Troisi, 2021. Gut Reactions: How Far Are We from Understanding and Manipulating the Microbiota Complexity and the Interaction with Its Host? Lessons from Autism Spectrum Disorder Studies. Nutrients 2021, 13(10), 3492; DOI: 10.3390/nu13103492
Autism is a group of neurodevelopmental disorders marked by early difficulties in social communication and repetitive behaviors, with both genetic and environmental factors contributing to its development. This review examines the role of the gut microbiome in autism, highlighting how methodological differences in studies have led to inconsistent results regarding the balance of harmful and beneficial bacteria. It also discusses the effects of gut microbial and dietary interventions on autism symptoms, noting the lack of standardized methods that hinder comparability. The authors suggest that a multi-omic longitudinal approach could help study metabolic changes related to microbiome alterations.
Zheng et al., 2021. The Role of Bacterial-Derived Aromatic Amino Acids Metabolites Relevant in Autism Spectrum Disorders: A Comprehensive Review. Front Neurosci. 21;15:738220. doi: 10.3389/fnins.2021.738220
Recent studies have highlighted the involvement of gut microbiota in the pathogenesis of autism spectrum disorders (ASD), showing microbial dysregulation in autistic patients and animal models. The gut microbiota influences food metabolism and produces metabolites that may be linked to neurodevelopmental disorders. Two specific metabolites, p-cresol sulfate and 4-ethylphenyl sulfate, have been associated with ASD and are derived from bacterial fermentation by commensal bacteria. These metabolites may enter the bloodstream, cross the blood-brain barrier, and impact microglial cells, potentially influencing neuroinflammation. This review discusses the significance of these metabolites as ASD potential biomarkers and intervention targets, while emphasizing the need for further research to establish their causal link with ASD pathophysiology.
Zheng et al., 2022. The Autism Spectrum Disorder-Associated Bacterial Metabolite p-Cresol Derails the Neuroimmune Response of Microglial Cells Partially via Reduction of ADAM17 and ADAM10 Int J Mol Sci. 23(19):11013. doi: 10.3390/ijms231911013
Children with autism show high levels of the bacterial metabolite p-cresol and its derivative pCS. This study reveals that pCS alters brain immune cell (microglia) activity by affecting key proteins ADAM10 and ADAM17, disrupting inflammation and immune responses. These findings suggest that gut-derived metabolites may contribute to autism by influencing brain immunity.
Beopoulos et al., 2022. Autism spectrum disorders pathogenesis: Toward a comprehensive model based on neuroanatomic and neurodevelopment considerations. Front Neurosci. 2022 Nov 3;16:988735. doi: 10.3389/fnins.2022.988735
Autism spectrum disorder (ASD) involves abnormal early brain development, with disrupted neural connections and an imbalance between brain excitation and inhibition. These changes begin in the womb due to faulty cortical layer formation and affect postnatal brain pruning, leading to a wide range of symptoms. The authors suggest that environmental changes affecting serotonin in early pregnancy may trigger ASD by altering brain development during a critical prenatal window.
Beopoulos et al., 2023. RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis. Front Neurosci. 2023 Feb 16;17:1101422. doi: 10.3389/fnins.2023.1101422
Autism spectrum disorders (ASDs) are complex and highly variable neurodevelopmental conditions with unclear causes. While genetic and epigenetic factors are known to contribute, this study highlights the potential central role of RNA epitranscriptomics in ASD pathogenesis. These RNA-based mechanisms, influenced by environmental factors like maternal inflammation, can disrupt early brain development by altering protein expression patterns. Even small early changes may lead to a wide range of neurological and behavioral abnormalities, helping explain ASD’s clinical and genetic diversity.
Zheng et al., 2023. The interaction between intestinal bacterial metabolites and phosphatase and tensin homolog in autism spectrum disorder. Mol Cell Neuroscience 124:103805. doi: 10.1016/j.mcn.2022.103805
Some substances produced by gut bacteria, like pCS and 4EPS, are found at higher levels in people with autism and can trigger autism-like behaviors in mice. This study looked at whether these substances affect a gene called PTEN, linked to autism. The results showed that PTEN is not involved in gut inflammation, but its levels are reduced in the brains of affected mice. In lab tests, pCS and 4EPS also lowered PTEN in brain immune cells, without directly altering immune responses. More research is needed to understand whether reduced PTEN affects brain connections and function in autism.
Rajaprakash M, et al. DNA methylation signatures of prenatal socioeconomic position associated with 36-month language outcomes. Res Dev Disabil. 2024 Nov;154:104846. doi: 10.1016/j.ridd.2024.104846
Socioeconomic position (SEP) during pregnancy can influence a child’s brain development and cause epigenetic changes—chemical modifications to DNA. This study looked at whether these changes, detected in placenta and umbilical cord blood at birth, are linked to language skills at age 3. The findings showed that lower prenatal SEP was associated with poorer expressive and receptive language abilities in early childhood. However, there was no link with general adaptive behavior. This research highlights how social disadvantages during pregnancy can leave biological marks that affect a child’s early language development.
Patti MA et al. Reproducibility between preschool and school-age Social Responsiveness Scale forms in the environmental influences on child health outcomes program. Autism Research 2024 Jun;17(6):1187-1204. doi.org/10.1002/aur.3147
Autism-related traits are more stable in older children but show more variability in early childhood. This study assessed the reliability of the Social Responsiveness Scale (SRS) across preschool and school-age versions. Results showed high overall consistency, especially for nonclinical traits, but more score variation was found in younger children, particularly those with autistic siblings, suggesting reduced reliability for early identification in clinical cases.
Schendel D. et al. 3-generation family histories of mental, neurologic, cardiometabolic, birth defect, asthma, allergy, and autoimmune conditions associated with autism: An open-source catalog of findings. Autism Res. 2024 Oct;17(10):2144-2155. doi: 10.1002/aur.3232.
A large Danish study of over 1.6 million births created an open-source catalog linking family history of various conditions (e.g., mental illness, neurological, autoimmune diseases) to autism risk. Results show wide variation in how different family health histories relate to autism, depending on relative type, sex, and intellectual disability status. This resource can support research into autism’s diverse causes and help better understand neurodiversity.
Yu EX et al. Prenatal metal exposures and child Social Responsiveness Scale scores in two prospective studies. Environ Health Insights. 2024 Feb 4;18:11786302231225313. doi: 10.1177/11786302231225313
This study examined whether prenatal exposure to metals (lead, mercury, manganese, selenium) affects autism-related behaviors in children. No clear links were found between metal levels and social responsiveness scores. Effects may vary by child sex or study group, highlighting the need for larger, more detailed studies.
- Troisi et al., 2020. Genome, Environment, Microbiome and Metabolome in Autism (GEMMA) Study Design: Biomarkers Identification for Precision Treatment and Primary Prevention of Autism Spectrum Disorders by an Integrated Multi-Omics Systems Biology Approach. Brain Sci. 2020 Oct 16;10(10):743. DOI: 10.3390/brainsci10100743
- Needham et al., 2021. Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry. 2021 Mar 1;89(5):451-462. doi: 10.1016/j.biopsych.2020.09.025. Beopoulos et al., 2021. Autonomic Nervous System Neuroanatomical Alterations Could Provoke and Maintain Gastrointestinal Dysbiosis in Autism Spectrum Disorder (ASD): A Novel Microbiome-Host Interaction Mechanistic Hypothesis. Nutrients. 2021 Dec 24;14(1):65. doi: 10.3390/nu14010065
- Lombardi and Troisi, 2021. Gut Reactions: How Far Are We from Understanding and Manipulating the Microbiota Complexity and the Interaction with Its Host? Lessons from Autism Spectrum Disorder Studies. Nutrients 2021, 13(10), 3492; DOI: 10.3390/nu13103492.
- Zheng et al., 2021. The Role of Bacterial-Derived Aromatic Amino Acids Metabolites Relevant in Autism Spectrum Disorders: A Comprehensive Review. Front Neurosci. 21;15:738220. doi: 10.3389/fnins.2021.738220
- Zheng et al., 2022. The Autism Spectrum Disorder-Associated Bacterial Metabolite p-Cresol Derails the Neuroimmune Response of Microglial Cells Partially via Reduction of ADAM17 and ADAM10 Int J Mol Sci. 23(19):11013. doi: 10.3390/ijms231911013
- Beopoulos et al., 2022. Autism spectrum disorders pathogenesis: Toward a comprehensive model based on neuroanatomic and neurodevelopment considerations. Front Neurosci. 2022 Nov 3;16:988735. doi: 10.3389/fnins.2022.988735. eCollection 2022.PMID: 36408388
- Beopoulos et al., 2023. RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis. Front Neurosci. 2023 Feb 16;17:1101422. doi: 10.3389/fnins.2023.1101422. eCollection 2023.PMID: 36875672
- Zheng et al., 2023. The interaction between intestinal bacterial metabolites and phosphatase and tensin homolog in autism spectrum disorder. Mol Cell Neuroscience 124:103805. doi: 10.1016/j.mcn.2022.103805
- Rajaprakash M*, Palmore M, Bakulski KM, Howerton E, Lyall K, Schmidt RJ, Newschaffer C, Croen LA, Hertz-Picciotto I, Volk HE, Ladd-Acosta C, Fallin MD. DNA methylation signatures of prenatal socioeconomic position associated with 36-month language outcomes. Research in Developmental Disabilities 2024 (in press).
- Patti, MA, Croen LA, Dickerson A, Joseph RM, Ames J, Ladd-Acosta C, Ozonoff S, Schmidt RJ, Volk H, Hipwell AE, Magee KE, Karagas M, McEvoy C, Landa R, Elliott M, Mitchell KD, D'Sa V, Deoni S, Pievsky M , Wu P-C, Barry F, Stanford J, Bilder D, Trasande L, Bush NR, Lyall K; program collaborators for Environmental Influences on Child Health Outcomes. Reproducibility between preschool and school-age Social Responsiveness Scale forms in the environmental influences on child health outcomes program. Autism Research 2024 Jun;17(6):1187-1204. doi: 10.1002/aur.3147. Epub 2024 May 25. PMID: 38794898; PMCID: PMC11186723
- Schendel, D., Ejlskov, L., Overgaard, M., Jinwala, Z., Kim, V., Parner, E., Kalkbrenner, A. E., Ladd Acosta, C., Fallin, M. D., Xie, S., Mortensen, P. B., & Lee, B. K. (2024). 3-generation family histories of mental, neurologic, cardiometabolic, birth defect, asthma, allergy, and autoimmune conditions associated with autism: An open-source catalog of findings. Autism Research, 1–12
- Yao M, Daniels J, Grosvenor L, Morrill V, Feinberg JI, Bakulski KM, Piven J, Hazlett HC, Shen MD, Newschaffer C, Lyall K, Schmidt RJ, Hertz-Picciotto I, Croen LA, Fallin MD, Ladd-Acosta C, Volk H, Benke K. Commonly used genomic arrays may lose information due to imperfect coverage of discovered variants for autism spectrum disorder. J Neurodev Disord. 2024 Sep 12;16(1):54. doi: 10.1186/s11689-024-09571-8. PMID: 39266988; PMCID: PMC11397030
- Yu, EX*, Dou, JF, Volk, HE, Bakulski, KM, Benke, K, Hertz-Picciotto, I, Schmidt, R, Newschaffer, CJ, Feinberg, JI, Daniels, J, Fallin, MD, Ladd-Acosta, C, Hamra, GB. Prenatal metal exposures and child Social Responsiveness Scale scores in two prospective studies. Environmental Health Insights. Environ Health Insights. 2024 Feb 4;18:11786302231225313. doi: 10.1177/11786302231225313. PMID: 38317694; PMCID: PMC10840406
Gastrointestine and nutrition research
- Asbjornsdottir et al., 2020. Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis. Nutrients. 2020 Jul 3;12(7):1982. doi: 10.3390/nu12071982
- Peralta-Marzal et al., 2021. The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders. Int. J. Mol. Sci. 2021, 22(18), 10052; DOI: 10.3390/ijms221810052
- Zheng et al, 2021. The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17. Int. J. Mol. Sci. 2021, 22(1), 118; DOI: 10.3390/ijms22010118. Gromova et al., 2021. Mechanisms of Glucose Absorption in the Small Intestine in Health and Metabolic Diseases and Their Role in Appetite Regulation. Nutrients 13: 2474, 2021. DOI: 10.3390/nu13072474
- Chiappori et al., 2022. Analysis of Faecal Microbiota and Small ncRNAs in Autism: Detection of miRNAs and piRNAs with Possible Implications in Host-Gut Microbiota Cross-Talk. Nutrients. 2022 Mar 23;14(7):1340. DOI: 10.3390/nu14071340.
- Lahaye E. and Fetissov S.O. 2024. Functional role of immunoglobulin G as an oxytocin-carrier protein. Peptides 177:171221, 2024, doi: 10.1016/j.peptides.2024.171221
Maitin-Shepard M. et al. Food, nutrition, and autism: from soil to fork. Am J Clin Nutr. 2024 Apr 25:S0002-9165(24)00443-X. doi: 10.1016/j.ajcnut.2024.04.020
Food and nutrition may influence both the development of autism spectrum disorder (ASD) and the quality of life of people with ASD, but many questions remain unanswered. On November 10, 2022, Tufts University hosted a meeting bringing together experts to discuss the current state of knowledge and evidence gaps in this area.
Topics included: the role of prenatal and early childhood diet, the gut microbiome, obesity, environmental toxins in food and packaging, and social influences on diet and ASD. Key findings suggested that prenatal folic acid may protect against ASD, while gestational obesity and chemical exposures may increase risk. The microbiome was highlighted as a possible link between diet and ASD-related behaviors.
The meeting emphasized the need for more research into biological mechanisms, the interplay between social and biological factors, and interventions involving diet, supplements, or microbiome modulation to improve life for people with ASD. The results will guide future research priorities in this field.
Prince N. et al. Prebiotic diet normalizes aberrant immune and behavioral phenotypes in a mouse model of autism spectrum disorder. Acta Sinica Pharmacologica 2024 doi.org/10.1038/s41401-024-01268-x
Autism Spectrum Disorder (ASD) is a group of neurodevelopmental disorders marked by difficulties in communication and behavior. Recent studies suggest that the gut-brain axis—especially involving the gut microbiota and the immune system—may play a key role in ASD development. Digestive issues and imbalanced gut bacteria have been linked to autism symptoms.
This study explored whether a prebiotic-rich diet (with galacto-oligosaccharides and fructo-oligosaccharides, GOS/FOS) could improve symptoms in mice prenatally exposed to valproic acid (VPA), a chemical known to induce autism-like traits. Mice on the GOS/FOS diet showed normalized gut bacteria, better gut barrier function, balanced immune responses, and reduced brain inflammation. Importantly, they also showed improved social behavior and cognitive function.
These findings suggest that dietary interventions targeting the gut microbiota may mitigate ASD-related symptoms and offer new therapeutic strategies.
Chiappori et al. Analysis of Faecal Microbiota and Small ncRNAs in Autism: Detection of miRNAs and piRNAs with Possible Implications in Host-Gut Microbiota Cross-Talk. Nutrients. 2022 Mar 23;14(7):1340. DOI: 10.3390/nu14071340
The gut is full of microorganisms that help keep our digestive system healthy and support the immune system. When this balance is disrupted—a condition called gut dysbiosis—it has been linked to various health issues, including autism. In children with autism, gut dysbiosis is associated with more severe symptoms and fewer beneficial bacteria. This study looked at how gut microbes interact with the body’s gene regulators, especially small RNA molecules like miRNAs and piRNAs, which can influence both human and microbial functions. Using advanced “omics” techniques, researchers analyzed the gut microbiome, fungi (mycobiome), and non-coding RNAs in children with and without autism. They found that children with autism had fewer healthy microbes, more inflammatory signals, and altered RNAs that may affect gut function and brain health. For the first time, specific RNAs were found in the stool of autistic children, offering a new way to study the gut–brain connection in autism.
Zheng et al, 2021. The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17. Int. J. Mol. Sci. 2021, 22(1), 118; DOI: 10.3390/ijms22010118.
Autism Spectrum Disorder (ASD) is a range of conditions marked by difficulties in social interaction and repetitive behaviors. While it’s believed to stem from early brain development issues, the exact causes are still unclear. Many people with ASD also experience gut problems, pointing to a possible brain–gut connection. This review focuses on two enzymes, ADAM10 and ADAM17, which are involved in both brain and gut functions. These enzymes can affect key proteins tied to brain development and inflammation—processes that are altered in ASD. Interestingly, they are also active in the intestines, where they help regulate gut health and immune responses. The review explores how ADAM10 and ADAM17 may play a role in linking gut and brain health in ASD, and how they could become targets for future treatments.
Gromova et al., 2021. Mechanisms of Glucose Absorption in the Small Intestine in Health and Metabolic Diseases and Their Role in Appetite Regulation. Nutrients 13: 2474, 2021. DOI: 10.3390/nu13072474
Metabolic diseases like obesity, metabolic syndrome, and type 2 diabetes are becoming more common worldwide. These conditions often involve high blood sugar (hyperglycemia), sometimes linked to overeating (hyperphagia). The small intestine plays a key role in absorbing glucose and helping regulate blood sugar levels, making it a target for new diabetes treatments. Scientists have discovered that a protein called SGLT1 is central to this process. However, while blocking glucose absorption in the gut can help lower blood sugar, it doesn’t necessarily help reduce appetite. This review highlights how glucose absorption works in the small intestine, how it changes in metabolic diseases, and why treating both high blood sugar and overeating may require different strategies.
Asbjornsdottir et al., 2020. Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis. Nutrients. 2020 Jul 3;12(7):1982. doi: 10.3390/nu12071982
Mental health issues affect up to 20% of children and teens worldwide, and they’re the leading cause of disability in young people. Recent studies suggest that problems with the gut—specifically increased “leakiness” of the intestinal barrier—might play a role in mental disorders. This review analyzed five observational studies looking at markers of intestinal permeability, like zonulin, in kids with ADHD, autism (ASD), and OCD. Children with ADHD and autism showed signs of altered gut barrier function, especially those with digestive issues or social difficulties. In contrast, kids with OCD didn’t show changes in zonulin but had other markers affected. Overall, higher levels of zonulin were found in kids with mental disorders, suggesting a possible gut-brain connection. More research is needed to fully understand how gut health and brain function are linked in these conditions.
Paediatric research
- Patrone et al., 2022. Optimization of Peripheral Blood Mononuclear Cell Extraction from Small Volume of Blood Samples: Potential Implications for Children-Related Diseases. Methods Protoc 2022;5(2):20. doi: 10.3390/mps5020020. PMID: 35314657; PMCID: PMC8938807.
- As Li, Y*, Hong X, Chandran A, Keet CA, Clish CB, Liang L, Jacobson LP, Wang X, Ladd-Acosta C. 2024. Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities. Annals of Allergy, Asthma & Immunology. 2024 Jun;132(6):705-712.e5. doi: 10.1016/j.anai.2024.03.001. Epub 2024 Mar 12. PMID: 38484838; PMCID: PMC11153017
- Hughes MM, Pas ET, Durkin MS, DaWalt LS, Bilder DA, Bakian AV, Amoakohene E, Shaw KA, Patrick ME, Salinas A, DiRienzo M, Lopez M, Williams S, McArthur D, Hudson A, Ladd-Acosta C, Schwenk Y, Baroud TM, Robinson Williams A, Washington A, Maenner MJ. 2024. Health Conditions, Education Services, and Transition Planning for Adolescents with Autism. Pediatrics. 2024 Apr 1;153(4):e2023063672. doi: 10.1542/peds.2023-063672. PMID: 38501189
As Li, Y. et al. Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities. Annals of Allergy, Asthma & Immunology. 2024 Jun;132(6):705-712.e5. doi: 10.1016/j.anai.2024.03.001
Previous research has suggested a link between prenatal use of acetaminophen (paracetamol) and a higher risk of childhood asthma, but it didn’t look closely at different asthma types or use direct measures of exposure. This new study used umbilical cord blood samples to detect acetaminophen and its byproducts at birth. The findings showed that babies exposed to acetaminophen shortly before birth were almost four times more likely to develop asthma without other allergic conditions like eczema or hay fever. Interestingly, this link was not seen in children who developed asthma with allergic comorbidities. These results suggest that prenatal acetaminophen exposure may influence specific types of asthma, offering new insights into early-life risk factors.
Hughes M.M. et al. Health Conditions, Education Services, and Transition Planning for Adolescents with Autism. Pediatrics. 2024 Apr 1;153(4):e2023063672. doi: 10.1542/peds.2023-063672.
This study looked at nearly 1,800 teenagers with autism in the U.S. to understand how often they experience other health issues and what kinds of educational support and future planning they receive. The most common coexisting conditions were ADHD (47%) and anxiety (39%), though anxiety was less often diagnosed in those with intellectual disabilities and in Black adolescents. The support services provided in schools varied greatly depending on the region. Teens with intellectual disabilities were less likely to get mental health services at school but more likely to have goals for independent living after high school. Notably, 37% of these students didn’t take standardized tests. Overall, the study found significant inequalities in how health conditions are identified and how support and services are provided, depending on race, ability, and location. Addressing these disparities will require collaboration between families, educators, and healthcare providers.
Patrone et al., 2022. Optimization of Peripheral Blood Mononuclear Cell Extraction from Small Volume of Blood Samples: Potential Implications for Children-Related Diseases. Methods Protoc 2022;5(2):20. doi: 10.3390/mps5020020
Taking blood samples from children with autism can be particularly challenging, especially for medical tests and research. However, studying certain blood cells, like peripheral blood mononuclear cells (PBMCs), is very important to understand immune responses and how the body reacts to medications. Among these, monocytic cells play a key role in inflammation and changes in the immune system, which are often seen in autism. This study presents a simple and reliable method to extract these cells from very small amounts of blood—making the process easier, less invasive, and more suitable for children with autism.
Microbiology
- Roussin et al., 2020. Role of the gut microbiota in the pathophysiology of autism spectrum disorder: clinical and pre-clinical evidence. Microorganisms 2020, 8(9), 1369. DOI: 10.3390/microorganisms8091369
- Peralta-Marzal et al., 2021. The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders. Int. J. Mol. Sci. 2021, 22, 10052. DOI: 10.3390/ijms221810052
Peralta-Marzal et al., 2021. The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders. Int. J. Mol. Sci. 2021, 22, 10052. DOI: 10.3390/ijms221810052
Autism Spectrum Disorder (ASD) is a group of neurodevelopmental conditions marked by difficulties in behavior, social interaction, and communication. It affects about 1 in 89 children in Europe. Since ASD varies greatly from person to person, diagnosing it is complex, and there’s no specific treatment yet. Many individuals with ASD also experience other health issues, especially intestinal problems, which may be linked to a disrupted communication system between the brain and the gut. This review highlights new studies showing that changes in the gut microbiota’s metabolism could play a role in ASD. These changes might influence both brain development and behavior. Understanding how gut bacteria and their metabolic activity interact with the body could help us uncover better diagnostic tools and new treatment approaches for autism.
Roussin et al., 2020. Role of the gut microbiota in the pathophysiology of autism spectrum disorder: clinical and pre-clinical evidence. Microorganisms 2020, 8(9), 1369. DOI: 10.3390/microorganisms8091369
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects about 1 in 160 people globally. While genetics play a major role, environmental factors are also thought to contribute. One area gaining attention is the gut: people with ASD often experience gastrointestinal issues at a much higher rate than others. Researchers have found that individuals with autism tend to have an altered gut microbiota—meaning their intestinal bacteria are out of balance—and this could affect brain function. Early studies suggest this imbalance may disrupt the immune system and the metabolism of tryptophan, a key amino acid involved in mood regulation. Promising results from both animal studies and a few human trials show that adjusting the gut microbiota through probiotics, antibiotics, or even fecal transplants might help improve behavior. Although research is still at an early stage, these findings suggest that the gut-brain connection may play a real role in autism and deserves further study.
Computational biology
- Di Nanni et al., 2020. Gene relevance based on multiple evidences in complex networks, Bioinformatics, Volume 36, Issue 3, 1 February 2020, Pages 865–871, DOI: 10.1093/bioinformatics/btz652
- Di Nanni et al., 2020. Network Diffusion Promotes the Integrative Analysis of Multiple Omics. Front. Genet. 11:106. DOI: 10.3389/fgene.2020.00106. Article views: 6273
- Mosca et al., 2021. Characterization and comparison of gene-centered human interactomes. Brief Bioinform. 2021 Nov 5;22(6):bbab153. DOI: 10.1093/bib/bbab153. Article views: 1388; Citations: 11
Peralta-Marzal L.N. et al. A robust microbiome signature for autism spectrum disorder across different studies using machine learning. Sci Rep. 2024 Jan 8;14(1):814. doi: 10.1038/s41598-023-50601-7
Autism Spectrum Disorder (ASD) is a complex condition marked by social difficulties and repetitive behaviors, often accompanied by other health issues. Many people with ASD also have gut problems, suggesting a link between the gut microbiome and autism. However, previous studies have struggled to agree on which specific gut bacteria are involved.
This study used a machine learning method called recursive ensemble feature selection (REFS) to analyze gut bacteria in children with ASD and their siblings. The researchers found 26 bacterial taxa that can help distinguish between ASD cases and non-ASD controls. Their approach showed good accuracy, with an AUC (Area Under Curve) of over 80% in one dataset and about 75% in two independent groups.
These findings show that gut bacteria could be used to help classify and understand ASD, and suggest the gut microbiome may be a promising target for future treatments. This method could also be applied to study microbiome patterns in other diseases.
Mosca et al. Characterization and comparison of gene-centered human interactomes. Brief Bioinform. 2021 Nov 5;22(6):bbab153. DOI: 10.1093/bib/bbab153
Inside our cells, proteins and other molecules constantly interact in complex networks, known as the interactome. Scientists use these networks to understand how cells function and how diseases develop. However, there’s no single, agreed-upon map of the human interactome. Different versions exist, created using various experimental techniques and databases. This study compared many of these interactome maps to see how similar or different they really are. The researchers analyzed aspects like network structure, how well the maps represent known protein complexes, biological pathways, and their ability to predict disease-related genes. The results revealed significant differences between the maps. This study helps researchers choose the most appropriate interactome for future studies, offering useful guidelines based on the strengths and weaknesses of each version.
Di Nanni et al. Gene relevance based on multiple evidence in complex networks. Bioinformatics, Volume 36, Issue 3, 1 February 2020, Pages 865–871, DOI: 10.1093/bioinformatics/btz652
Multi-omics approaches combine different types of biological data—like genes, proteins, and metabolites—to give a more complete view of what’s happening in diseases such as cancer. However, analyzing this complex data is challenging. In this study, researchers developed a new method called mND, which uses network-based analysis to identify important genes by looking at how closely connected they are to other altered genes in a biological network. This method performs better than previous techniques in spotting key genes involved in disease, especially when combining multiple layers of biological information. It’s also effective at identifying known cancer-related genes. Because it’s so flexible, this method can also be used in other fields like single-cell studies, making it a powerful tool for biomedical research.
Di Nanni et al., 2020. Network Diffusion Promotes the Integrative Analysis of Multiple Omics. Front. Genet. 11:106. DOI: 10.3389/fgene.2020.00106.
One of the biggest challenges in bioinformatics is finding effective ways to combine different types of genetic data. Network-based methods help by using the known relationships between genes. A particularly powerful technique called network diffusion (or network propagation) has become popular in recent years. This method spreads information across gene networks, helping researchers detect patterns and connections between genes that are close to each other. It works with many kinds of biological data and helps make sense of complex datasets by highlighting system-wide changes. This review looks at how network diffusion is currently used to integrate omics data (like genomics or proteomics), the advantages it offers, and how it might evolve in the future. As new data types emerge—such as single-cell data—network diffusion is expected to become even more central in discovering how biological systems work.
Di Nanni et al. Network-Based Integrative Analysis of Genomics, Epigenomics and Transcriptomics in Autism Spectrum Disorders. Int J Mol Sci. 2019 Jul 9;20(13). pii: E3363. DOI: 10.3390/ijms20133363.
Autism Spectrum Disorders (ASDs) are thought to be influenced by many different genes, which makes understanding their causes complex. To tackle this, researchers are now using gene networks and multi-omics data (like genomics, epigenomics, and transcriptomics) to get a fuller picture of what’s happening at the molecular level.
In this study, scientists performed a network-based meta-analysis of genes previously linked to autism. They ranked these genes based on how important they are in cell signaling networks, how strong the evidence is for their role in ASD, and how many different types of molecular changes affect them. Many of the top-ranked genes matched those in trusted autism databases, like SFARI.
The study helps prioritize key genes involved in autism, making it easier to identify potential targets for new treatments and encouraging more focused research in the future.
Generalised science
- Di Nanni et al., 2019. Network-Based Integrative Analysis of Genomics, Epigenomics and Transcriptomics in Autism Spectrum Disorders. Int J Mol Sci. 2019 Jul 9;20(13). pii: E3363. DOI: 10.3390/ijms20133363.
- Cupaioli et al., 2019. Assessment of haptoglobin alleles in autism spectrum disorders. Sci Rep. 2020 May 8;10(1):7758. DOI 10.1038/s41598-020-64679-w. 5
- Cupaioli et al., 2020. Change of Communication Strategy to Increase Engagement during the SARS-Cov-2 Pandemic: The Experience of the European GEMMA Project in Italy. International Journal of Humanities Social Sciences and Education 7(9)128-137 2020 DOI: 10.20431/2349-0381.0709013
- Roussin L, Gry E, Macaron M, Ribes S, Monnoye M, Douard V, Naudon L, Rabot S. 2024. Microbiota influence on behavior: integrative analysis of serotonin metabolism and behavioral profile in germ-free mice. The FASEB Journal 2024; 38: e23648. https://doi.org/10.1096/fj.202400334R.
- Prince N, Peralta Marzal L, Markidi A, Ahmed S, Adolfs Y, Pasterkamp RJ, Himanshu K, Roeselers G, Garssen J, Kraneveld A, Perez-Pardo P. Prebiotic diet normalizes aberrant immune and behavioral phenotypes in a mouse model of autism spectrum disorder. Accepted, Acta Sinica Pharmacologica 2024
- Peralta-Marzal LN, Rojas-Velazquez D, Rigters D, Prince N, Garssen J, Kraneveld AD, Perez-Pardo P, Lopez-Rincon A. A robust microbiome signature for autism spectrum disorder across different studies using machine learning. Sci Rep. 2024 Jan 8;14(1):814. doi: 10.1038/s41598-023-50601-7
- Maitin-Shepard M, O'Tierney-Ginn P, Kraneveld AD, Lyall K, Fallin D, Arora M, Fasano A, Mueller NT, Wang X, Caulfield LE, Dickerson AS, Diaz Heijtz R, Tarui T, Blumberg JB, Holingue C, Schmidt RJ, Garssen J, Almendinger K, Lin PD, Mozaffarian D. Food, nutrition, and autism: from soil to fork. Am J Clin Nutr. 2024 Apr 25:S0002-9165(24)00443-X. doi: 10.1016/j.ajcnut.2024.04.020
- Kalkbrenner AE, Zheng C, Yu J, Jenson TE, Kuhlwein T, Ladd-Acosta C, Grove J, Schendel D. 2024. Method for Testing Etiologic Heterogeneity Among Noncompeting Diagnoses, Applied to Impact of Perinatal Exposures on Autism and Attention Deficit Hyperactivity Disorder. Epidemiology. 2024 Sep 1;35(5):689-700. doi: 10.1097/EDE.0000000000001760. Epub 2024 Jul 18. PMID: 39024025; PMCID: PMC11309336
Roussin L. et al. Microbiota influence on behavior: integrative analysis of serotonin metabolism and behavioral profile in germ-free mice. The FASEB Journal 2024; 38: e23648. https://doi.org/10.1096/fj.202400334R
Previous research has shown that germ-free (GF) animals often exhibit altered anxiety-like and social behaviors, along with changes in serotonin (5-HT) metabolism in the brain and gut. In this study, researchers compared GF male mice with conventional (CV) mice to investigate behaviors and serotonin metabolism. The GF mice showed reduced locomotor activity and some signs of increased anxiety-like behavior.
Gene analysis revealed no significant changes in brain serotonin genes, but in the gut, differences in serotonin-related gene expression were observed. For example, TPH1 expression was lower in the colon of GF mice, while HTR4 expression increased in both the colon and cecum. Interestingly, SLC6A4 expression was higher in the ileum and colon of GF mice compared to CV mice.
These results reinforce the idea that the gut microbiota plays a role in regulating behavior, though variations between studies suggest that both genetic and environmental factors also influence this regulation. Although brain serotonin levels were not affected by the lack of microbiota, gut serotonin metabolism showed significant differences, with varying roles of microbiota across different parts of the GI tract.
Kalkbrenner A.E. et al. Method for Testing Etiologic Heterogeneity Among Noncompeting Diagnoses, Applied to Impact of Perinatal Exposures on Autism and Attention Deficit Hyperactivity Disorder. Epidemiology. 2024 Sep 1;35(5):689-700. doi: 10.1097/EDE.0000000000001760
Understanding whether certain risk factors affect different subtypes of neurodevelopmental disorders differently helps clarify causes and improve research accuracy. Many mental health conditions, like autism and ADHD, often appear together and have complex, overlapping symptoms.
Researchers developed a new statistical method to analyze how risk factors (like urban living, maternal smoking during pregnancy, and parental psychiatric history) affect these subtypes in children. They compared three groups: children diagnosed with only autism, only ADHD, and those with both autism and ADHD.
They found that: urban living was most strongly associated with having both autism and ADHD, maternal smoking was linked only to ADHD, parental psychiatric history was linked to all subtypes similarly.
The new method better uses available data, avoids diagnostic confusion, and could be applied to other complex disorders. It also helps determine how different causes affect different subgroups of a condition.
Lahaye E. and Fetissov S.O. Functional role of immunoglobulin G as an oxytocin-carrier protein. Peptides 177:171221, 2024, doi: 10.1016/j.peptides.2024.171221
It’s long been known that oxytocin, the “love hormone,” travels in the blood attached to a carrier protein, but until recently, no one knew exactly what that protein was. A new study has revealed that about 60% of oxytocin in our blood is bound to Immunoglobulin G (IgG), a type of antibody, which acts as its carrier. This oxytocin–IgG complex not only helps transport the hormone but also plays a role in how oxytocin affects behavior and brain function. The study suggests that this interaction could be important for understanding conditions like anxiety, depression, and social disorders. Interestingly, gut bacteria might influence the production of this IgG, opening up exciting possibilities for new treatments that enhance oxytocin’s positive effects by targeting the gut–immune–brain connection.
Cupaioli et al., 2019. Assessment of haptoglobin alleles in autism spectrum disorders. Sci Rep. 2020 May 8;10(1):7758. DOI 10.1038/s41598-020-64679-w. 5
One theory about the causes of Autism Spectrum Disorders (ASD) involves a weakened intestinal barrier, which might allow harmful substances to reach the body and brain, especially in individuals with gastrointestinal (GI) issues. A protein called zonulin, encoded by the HP2 gene, is known to increase intestinal permeability by loosening the tight junctions between intestinal cells.
Researchers studied whether the HP2 gene variant was more common in Italian individuals with ASD compared to healthy controls. They used both genetic testing and computational analysis to detect this variant. Surprisingly, they found no link between HP2 and ASD, even in individuals with GI problems.
This suggests that other members of the zonulin family or environmental factors might be responsible for increased gut permeability in ASD, not the HP2 gene. The study also introduced a new method to detect HP gene variants with good accuracy.
Cupaioli et al. Change of Communication Strategy to Increase Engagement during the SARS-Cov-2 Pandemic: The Experience of the European GEMMA Project in Italy. International Journal of Humanities Social Sciences and Education 7(9)128-137 2020 DOI: 10.20431/2349-0381.0709013
Effective communication is crucial for scientific research. The GEMMA project, part of the EU’s Horizon 2020 program, studies autism and aims to enroll 600 at-risk infants across several countries. Early on, the project’s communication team focused on engaging stakeholders, especially via social media and a dedicated website, to support recruitment.
However, the COVID-19 lockdown disrupted both recruitment and traditional schooling. Children with autism, who often struggle with changes in routine, faced particular challenges with remote education. In response, GEMMA adapted its communication plan to the pandemic by promoting inclusive webinars and educational apps focused on technology and inclusion. These tools helped autistic children, their parents, and teachers cope with remote learning and stay engaged.
The initiative proved that tailored digital tools can be effective not only for education but also for maintaining public involvement and communication during emergencies.